Attitudes Toward the Use of Medical Cannabis and the Perceived Efficacy, Side-effects and Risks: A Survey of Patients, Nurses and Physicians

References

• Abdel-Khalek, A. M. 2006. Measuring happiness with a single-item scale. Social Behavior and Personality: An International Journal 34 (2):139–50. doi:10.2224/sbp.2006.34.2.139.
   Web of Science ®Google Scholar
• Abrams, D. I. 2018. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European Journal of Internal Medicine 49:7–11. doi:10.1016/j.ejim.2018.01.003.
   PubMed Web of Science ®Google Scholar
• Adamson, S. J., F. J. Kay-Lambkin, A. L. Baker, T. J. Lewin, L. Thornton, B. J. Kelly, and J. D. Sellman. 2010. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug and Alcohol Dependence 110 (1–2):137–43. doi:10.1016/j.drugalcdep.2010.02.017.
   PubMed Web of Science ®Google Scholar
• Adler, J. N., and J. A. Colbert. 2013. Medicinal use of marijuana–polling results. The New England Journal of Medicine 368 (22):e30. doi:10.1056/NEJMclde1305159.
   PubMed Web of Science ®Google Scholar
• Amato, L., S. Minozzi, Z. Mitrova, E. Parmelli, R. Saulle, F. Cruciani, and M. Davoli. 2017. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiologia e Prevenzione 41(5–6):279–293. doi:10.19191/ep17.5-6.ad01.069.
   PubMed Web of Science ®Google Scholar
• Anderson, S. P., D. M. Zylla, D. M. McGriff, and T. J. Arneson. 2019. Impact of medical cannabis on patient-reported symptoms for patients with cancer enrolled in Minnesota’s medical cannabis program. Journal of Oncology Practice 15 (4):e338–e345. doi:10.1200/JOP.18.00562.
   PubMed Web of Science ®Google Scholar
• Arnfinsen, J. L., and A. Kisa. 2020. Assessment of Norwegian physicians’ knowledge, experience and attitudes towards medical cannabis. Drugs: Education, Prevention and Policy 28 (2):165–71.
   Web of Science ®Google Scholar
• Balneaves, L. G., A. Alraja, D. Ziemianski, F. McCuaig, and M. Ware. 2018. A national needs assessment of Canadian nurse practitioners regarding cannabis for therapeutic purposes. Cannabis and Cannabinoid Research 3 (1):66–73. doi:10.1089/can.2018.0002.
   PubMedGoogle Scholar
• Bar-Sela, G., A. Avisar, R. Batash, and M. Schaffer. 2014. Is the clinical use of cannabis by oncology patients advisable? Current Medicinal Chemistry 21 (17):1923–30. doi:10.2174/0929867321666140304151323.
   PubMed Web of Science ®Google Scholar
• Bar-Sela, G., M. Vorobeichik, S. Drawsheh, A. Omer, V. Goldberg, and E. Muller. 2013. The medical necessity for medicinal cannabis: Prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care. In Evidence-Based Complementary and Alternative Medicine, Article ID 510392, 8.
   Google Scholar
• Benbadis, S. R., J. Sanchez-Ramos, A. Bozorg, M. Giarratano, K. Kalidas, L. Katzin, and T. Zesiewicz. 2014. Medical marijuana in neurology. Expert Review of Neurotherapeutics 14 (12):1453–65. doi:10.1586/14737175.2014.985209.
   PubMed Web of Science ®Google Scholar
• Bonn-Miller, M. O., M. T. Boden, M. M. Bucossi, and K. A. Babson. 2014. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse 40 (1):23–30. doi:10.3109/00952990.2013.821477.
   PubMed Web of Science ®Google Scholar
• Brady, J. P., D. Bruce, E. Foster, and M. Shattell. 2020. Self-Efficacy in Researching and Obtaining Medical Cannabis by Patients with Chronic Conditions. Health Education & Behavior 47 (5):740–48. doi:10.1177/1090198120914249.
   PubMed Web of Science ®Google Scholar
• Braun, I. M., A. Wright, J. Peteet, F. L. Meyer, D. P. Yuppa, D. Bolcic-Jankovic, and J. A. Tulsky. 2018. Medical oncologists’ beliefs, practices, and knowledge regarding marijuana used therapeutically: A nationally representative survey study. Journal of Clinical Oncology 36 (19):1957–62. doi:10.1200/JCO.2017.76.1221.
   PubMed Web of Science ®Google Scholar
• Bruce, D., E. Foster, and M. Shattell. 2019. Perceived efficacy of medical cannabis in the treatment of co-occurring health-related quality of life symptoms. Behavioral Medicine 6:1–5.
   Google Scholar
• Bylund, C. L., J. A. Gueguen, T. A. D’Agostino, Y. Li, and E. Sonet. 2010. Doctor–patient communication about cancer-related internet information. Journal of Psychosocial Oncology 28 (2):127–42. doi:10.1080/07347330903570495.
   PubMed Web of Science ®Google Scholar
• Caligiuri, F. J., E. E. Ulrich, and K. J. Welter. 2018. Pharmacy student knowledge, confidence and attitudes toward medical cannabis and curricular coverage. American Journal of Pharmaceutical Education 82 (5):6296. doi:10.5688/ajpe6296.
   PubMed Web of Science ®Google Scholar
• Canada, H. (2020). Cannabis for medical purposes under the Cannabis Act: Information and improvements. Retrieved May, 7, 2020: https://www.Canada.ca/en/health-Canada/services/drugs-medication/cannabis/medical-use-cannabis.html#_Access_to_cannabis
   Google Scholar
• Carlini, B. H., S. B. Garrett, and G. T. Carter. 2017. Medicinal cannabis: A survey among health care providers in Washington state. American Journal of Hospice and Palliative Medicine® 34 (1):85–91. doi:10.1177/1049909115604669.
   PubMed Web of Science ®Google Scholar
• Donovan, K. A., Y. D. Chang, R. Oberoi-Jassal, S. Rajasekhara, J. Smith, M. Haas, and D. G. Portman. 2019. Relationship of cannabis use to patient-reported symptoms in cancer patients seeking supportive/palliative care. Journal of Palliative Medicine 22 (10):1191–95. doi:10.1089/jpm.2018.0533.
   PubMed Web of Science ®Google Scholar
• Evanoff, A. B., T. Quan, C. Dufault, M. Awad, and L. J. Bierut. 2017. Physicians-in-training are not prepared to prescribe medical marijuana. Drug and Alcohol Dependence 180:151–55. doi:10.1016/j.drugalcdep.2017.08.010.
   PubMed Web of Science ®Google Scholar
• First, M., R. Spitzer, M. Gibbon, and J. Williams. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders, Non-Patient Edition. New York: New York State Psychiatric Institute. (p.147).
   Google Scholar
• Grella, C. E., L. Rodriguez, and T. Kim. 2014. Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in Los Angeles. Journal of Psychoactive Drugs 46 (4):263–72. doi:10.1080/02791072.2014.944960.
   PubMed Web of Science ®Google Scholar
• Hadland, S. E., J. R. Knight, and S. K. Harris. 2015. Medical marijuana: Review of the science and implications for developmental behavioral pediatric practice. Journal of Developmental and Behavioral Pediatrics 36 (2):115–23. doi:10.1097/DBP.0000000000000129.
   PubMed Web of Science ®Google Scholar
• Hays, R. D., B. D. Schalet, K. L. Spritzer, and D. Cella. 2017. Two-item PROMIS® global physical and mental health scales. Journal of Patient-Reported Outcomes 1 (2):1–5. doi:10.1186/s41687-017-0003-8.
   PubMedGoogle Scholar
• Huang, Z., I. V. Kohler, and F. Kämpfen. 2020. A single-item visual analogue scale (VAS) measure for assessing depression among college students. Community Mental Health Journal 56 (2):355–67. doi:10.1007/s10597-019-00469-7.
   PubMed Web of Science ®Google Scholar
• Israel Bureau of Statistics. (2019). Israel statistics annual data- 2019. Retrieved May 22, 2020 from: https://www.cbs.gov.il/he/publications/doclib/2019/4.shnatoneducation/diagrams4.pdf
   Google Scholar
• Israel Ministry of Health. (2021). License for Cannabis Use guidelines. The Medical Cannabis Unit, circular no. 106. 1-12 [In Hebrew]. Retrieved March, 2021: https://www.health.gov.il/hozer/CN_106_2019.pdf#page=3
   Google Scholar
• Kondrad, E. C., A. J. Reed, M. J. Simpson, and D. E. Nease. 2018. Lack of communication about medical marijuana use between doctors and their patients. The Journal of the American Board of Family Medicine 31 (5):805–08. doi:10.3122/jabfm.2018.05.170462.
   PubMed Web of Science ®Google Scholar
• Kondrad, E., and A. Reid. 2013. Colorado family physicians’ attitudes toward medical marijuana. The Journal of the American Board of Family Medicine 26 (1):52–60. doi:10.3122/jabfm.2013.01.120089.
   PubMed Web of Science ®Google Scholar
• Krauss, M. J., S. J. Sowles, A. Sehi, E. L. Spitznagel, C. J. Berg, L. J. Bierut, and P. A. Cavazos-Rehg. 2017. Marijuana advertising exposure among current marijuana users in the US. Drug and Alcohol Dependence 174:192–200. doi:10.1016/j.drugalcdep.2017.01.017.
   PubMed Web of Science ®Google Scholar
• Lee, C. M., C. Neighbors, C. S. Hendershot, and J. R. Grossbard. 2009. Development and preliminary validation of a comprehensive marijuana motives questionnaire. Journal of Studies on Alcohol and Drugs 70 (2):279–87.
   PubMed Web of Science ®Google Scholar
• Lewis, N., and S. R. Sznitman. 2017. You brought it on yourself: The joint effects of message type, stigma, and responsibility attribution on attitudes toward medical cannabis. Journal of Communication 67 (2):181–202. doi:10.1111/jcom.12287.
   Web of Science ®Google Scholar
• Lewis, N., and S. R. Sznitman. 2019. Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization? International Journal of Drug Policy 73:219–27. doi:10.1016/j.drugpo.2019.01.005.
   PubMed Web of Science ®Google Scholar
• Lombardi, E., J. Gunter, and E. Tanner. 2020. Ohio physician attitudes toward medical Cannabis and Ohio’s medical marijuana program. Journal of Cannabis Research 2 (16):1–9. doi:10.1186/s42238-020-00025-1.
   Google Scholar
• Mathern, G. W., L. Beninsig, and A. Nehlig. 2015. Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: Result of Epilepsia’s survey. Epilepsia 56 (1):1–6. doi:10.1111/epi.12843.
   PubMed Web of Science ®Google Scholar
• Melnikov, S., A. Aboav, E. Shalom, S. Phriedman, and K. Khalaila. 2021. The effect of attitudes, subjective norms and stigma on health‐care providers’ intention to recommend medicinal cannabis to patients. International Journal of Nursing Practice 27 (1):e12836. doi:10.1111/ijn.12836.
   PubMed Web of Science ®Google Scholar
• Michalec, B., L. Rapp, and T. Whittle. 2015. Assessing physicians’ perspectives and knowledge of medical marijuana and the Delaware Medical Marijuana Act. The Journal of Global Drug Policy and Practice 9 (3):1–24.
   Google Scholar
• Naftali, T., L. B. L. Schleider, F. S. Benjaminov, I. Lish, F. M. Konikoff, and Y. Ringel. 2019. Medical cannabis for inflammatory bowel disease: Real-life experience of mode of consumption and assessment of side-effects. European Journal of Gastroenterology & Hepatology 31 (11):1376–81. doi:10.1097/MEG.0000000000001565.
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering and Medicine. 2017. “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.” National Academies Press. Washington, DC
   Google Scholar
• Ng, J. Y., K. Gilotra, S. Usman, Y. Chang, and J. W. Busse. 2021. Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: A qualitative research study. CMAJ Open 9 (2):E342. doi:10.9778/cmajo.20200187.
   PubMedGoogle Scholar
• Nunberg, H., B. Kilmer, R. L. Pacula, and J. R. Burgdorf. 2011. An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis 4:1. doi:10.2202/1941-2851.1017.
   PubMedGoogle Scholar
• Patel, R. S., S. Kamil, M. R. Shah, N. N. Bhimanadham, and S. Imran. 2019. Pros and Cons of Marijuana in Treatment of Parkinson’s Disease. Cureus 11 (6):e4813. doi:10.7759/cureus.4813.
   PubMed Web of Science ®Google Scholar
• Pereira, L., M. J. Núñez-Iglesias, E. M. Domínguez-Martís, D. López-Ares, M. González-Peteiro, and S. Novío. 2020. Nursing Students’ Knowledge and Attitudes Regarding Medical Marijuana: A Descriptive Cross-Sectional Study. International Journal of Environmental Research and Public Health 17 (7):2492. doi:10.3390/ijerph17072492.
   PubMed Web of Science ®Google Scholar
• Robinson, D., S. Ritter, L. Zadik-Weiss, H. Ounallah-Saad, N. Abu-Ahmad, R. Kashkoosh, and R. Or. 2020. Bridging the Accessibility Gap of Cannabinoid Medicine and Arabic Culture. Rambam Maimonides Medical Journal 11 (1):e0010. doi:10.5041/RMMJ.10392.
   PubMed Web of Science ®Google Scholar
• Sagy, I., T. Peleg-Sagy, L. Barski, L. Zeller, and A. Jotkowitz. 2018. Ethical issues in medical cannabis use. European Journal of Internal Medicine 49:20–22. doi:10.1016/j.ejim.2018.01.016.
   PubMed Web of Science ®Google Scholar
• Schlag, A. K., S. E. O’Sullivan, R. R. Zafar, and D. J. Nutt. 2021. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics. Neuropharmacology 191, 108586.
   Google Scholar
• Schleider, L. B. L., R. Mechoulam, V. Lederman, M. Hilou, O. Lencovsky, O. Betzalel, and V. Novack. 2018. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. European Journal of Internal Medicine 49:37–43. doi:10.1016/j.ejim.2018.01.023.
   PubMed Web of Science ®Google Scholar
• Sideris, A., F. Khan, A. Boltunova, G. Cuff, C. Gharibo, and L. V. Doan. 2018. New York physicians’ perspectives and knowledge of the state medical marijuana program. Cannabis and Cannabinoid Research 3 (1):74–84. doi:10.1089/can.2017.0046.
   PubMedGoogle Scholar
• Steele, G., T. Arneson, and D. Zylla. 2019. A comprehensive review of cannabis in patients with cancer: Availability in the USA, general efficacy, and safety. Current Oncology Reports 21 (1):10. doi:10.1007/s11912-019-0757-7.
   PubMed Web of Science ®Google Scholar
• Street, R. L., and P. Haidet. 2011. How well do doctors know their patients? Factors affecting physician understanding of patients’ health beliefs. Journal of General Internal Medicine 26 (1):21–27. doi:10.1007/s11606-010-1453-3.
   PubMed Web of Science ®Google Scholar
• Swift, W., P. Gates, and P. Dillon. 2005. Survey of Australians using cannabis for medical purposes. Harm Reduction Journal 2 (1):18. doi:10.1186/1477-7517-2-18.
   PubMedGoogle Scholar
• Szaflarski, M., P. McGoldrick, L. Currens, D. Blodgett, H. Land, J. P. Szaflarski, and E. Segal. 2020. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists. Epilepsy & Behavior 109:107102. doi:10.1016/j.yebeh.2020.107102.
   PubMed Web of Science ®Google Scholar
• Sznitman, S. R., and N. Lewis. 2015. Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage. International Journal of Drug Policy 26 (5):446–52. doi:10.1016/j.drugpo.2015.01.010.
   PubMed Web of Science ®Google Scholar
• Sznitman, S. R., and N. Lewis. 2018. Examining effects of medical cannabis narratives on beliefs, attitudes, and intentions related to recreational cannabis: A web-based randomized experiment. Drug and Alcohol Dependence 185:219–25. doi:10.1016/j.drugalcdep.2017.11.028.
   PubMed Web of Science ®Google Scholar
• Sznitman, S. R. 2020. Trends in medical cannabis licensure, Israel, 2013–2018. Drug and Alcohol Review 39 (6):763–67. doi:10.1111/dar.13116.
   PubMed Web of Science ®Google Scholar
• Szyliowicz, D., and P. Hilsenrath. 2019. Medical marijuana knowledge and attitudes: A survey of the California pharmacists’ association. Journal of Primary Care & Community Health 10:1–6. doi:10.1177/2150132719831871.
   Web of Science ®Google Scholar
• The European Cannabis Report, 3rd edition. (2018). Germany MMJ research report, 29–34. Retrieved May, 7, 2020:http://www.amp-eu.com/wp-content/uploads/2019/01/PP_German-MMJ-research-report.pdf
   Google Scholar
• Troutt, W. D., and M. D. DiDonato. 2015. Medical cannabis in Arizona: Patient characteristics, perceptions, and impressions of medical cannabis legalization. Journal of Psychoactive Drugs 47 (4):259–66. doi:10.1080/02791072.2015.1074766.
   PubMed Web of Science ®Google Scholar
• Van Ameringen, M., J. Zhang, B. Patterson, and J. Turna. 2020. The role of cannabis in treating anxiety: An update. Current Opinion in Psychiatry 33 (1):1–7. doi:10.1097/YCO.0000000000000566.
   PubMed Web of Science ®Google Scholar
• Waissengrin, B., D. Urban, Y. Leshem, M. Garty, and I. Wolf. 2015. Patterns of use of medical cannabis among Israeli cancer patients: A single institution experience. Journal of Pain and Symptom Management 49 (2):223–30. doi:10.1016/j.jpainsymman.2014.05.018.
   PubMed Web of Science ®Google Scholar
• Wilkie, G., B. Sakr, and T. Rizack. 2016. Medical marijuana use in oncology: A review. JAMA Oncology 2 (5):670–75. doi:10.1001/jamaoncol.2016.0155.
   PubMed Web of Science ®Google Scholar
• Zarrabi, A. J., J. W. Welsh, R. Sniecinski, K. Curseen, T. Gillespie, W. Baer, … V. Singh. 2020. Perception of benefits and harms of medical cannabis among seriously ill patients in an outpatient palliative care practice. Journal of Palliative Medicine 23 (4):558–62. doi:10.1089/jpm.2019.0211.
   PubMed Web of Science ®Google Scholar
• Zolotov, Y., O. G. Cohen, P. A. Findley, A. Reznik, R. Isralowitz, and S. Willard. 2021. Attitudes and knowledge about medical cannabis among Israeli and American nursing students. Nurse Education Today 99:104789. doi:10.1016/j.nedt.2021.104789.
   PubMed Web of Science ®Google Scholar
• Zolotov, Y., S. Sznitman, and S. Vulfsons. 2019b. Validation of Clinical Vignettes to Explore Medical Cannabis Practices. The Israel Medical Association Journal 21 (11):710–15.
   PubMed Web of Science ®Google Scholar
• Zolotov, Y., S. Vulfsons, D. Zarhin, and S. Sznitman. 2018. Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. International Journal of Drug Policy 57:4–10. doi:10.1016/j.drugpo.2018.03.025.
   PubMed Web of Science ®Google Scholar
• Zolotov, Y., S. Vulfsons, and S. Sznitman. 2019a. Predicting Physicians’ intentions to recommend medical Cannabis. Journal of Pain and Symptom Management 58 (3):400–07. doi:10.1016/j.jpainsymman.2019.05.010.
   PubMed Web of Science ®Google Scholar